Editorial: What Are the Remaining Challenges before Blood-Based Biomarkers for Alzheimer's Disease Can Be Used in Clinical Practice?
J Prev Alzheimers Dis
.
2022;9(4):567-568.
doi: 10.14283/jpad.2022.89.
Author
T Bittner
1
Affiliation
1
Tobias Bittner PhD, F Hoffmann-La Roche AG, Switzerland,
[email protected]
.
PMID:
36281660
DOI:
10.14283/jpad.2022.89
No abstract available
Publication types
Editorial
Comment
MeSH terms
Alzheimer Disease* / diagnosis
Biomarkers
Humans
Substances
Biomarkers